Hydroxychloroquine Market: A review on recent progress, Product Type, Distribution Channel, Disease, Regional Analysis and Industry Forecast, 2020-2027

As per the latest research report by Allied Market Research,
The global hydroxychloroquine market size was valued at $1.9 billion in 2019, and is anticipated to generate $4.6 billion by 2027. The market is projected to experience growth at a CAGR of 7.9% from 2020 to 2027. The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps to be taken to gain competitive advantage.

Download Sample Report: https://www.alliedmarketresearch.com/request-sample/7502

Based on region, Asia-Pacific held the largest market share of more than four-fifths of the global hydroxychloroquine market in 2019, and is expected to maintain its lead position during the forecast period. Moreover, this region is expected to register the highest CAGR of 8.2% from 2020 to 2027. This is due to presence of major market players in countries such as India and China and increase in demand for the medication with high incidence of malaria in South-east Asian countries. However, North America would grow at a CAGR of 4.4% during the forecast period.

Hydroxychloroquine market growth is driven by increase in demand for HCQ as a potential treatment option amidst the Covid-19 pandemic and surge in cases of malaria. However, ban in several countries due to lack of study data and fatal side-effects of the medicine hinder the market growth. On the other hand, repurposing of HCQ as an anti-cancer drug creates new opportunities in the coming years.

Based on product type, the API segment accounted for the highest market share in 2019, contributing to more than half of the global hydroxychloroquine market, and is estimated to maintain its leadership status during the forecast period. This is due to its efficacy in diagnosis, prevention, cure, treatment, and mitigation purposes. However, the tablet segment is projected to manifest the fastest CAGR of 8.4% from 2020 to 2027, owing to ease in availability and cost-effectiveness.

Interested in Procuring this Report? Visit Here: https://www.alliedmarketresearch.com/hydroxychloroquine-market/purchase-options

Based on disease, the malaria segment held more than two-fifths of the total market share of the global hydroxychloroquine market in 2019, and is estimated to maintain its highest contribution throughout the forecast period. Moreover, this segment is expected to witness the fastest CAGR of 29.8% from 2020 to 2027. This is attributed to rise in prevalence of malaria in the African region and widespread usage as an anti-malarial drug. The report also analyzes segments including rheumatoid arthritis, lupus erythematosus, coronavirus, and others.

Market players grabbing the largest pie:

• Cadila Healthcare Ltd.

• Hikma Pharmaceuticals PLC

• Ipca Laboratories Ltd.

• Mylan N.V.

• Novartis AG

• Pfizer Inc.

• Sanofi S.A.

• Taj Pharmaceuticals Ltd.

• Teva Pharmaceutical Industries Ltd.

• Torrent Pharmaceuticals Ltd.

• Zydus Cadila

Browse Full Report Summary:
https://www.alliedmarketresearch.com/hydroxychloroquine-market-A07137

Key Benefits For Stakeholders

The report provides an in-depth analysis and hydroxychloroquine market forecast along with the current trends and future estimations.
This report highlights the key drivers, opportunities, and restraints of the hydroxychloroquine market along with the impact analysis during the forecast period.
Porter's five forces analysis helps to analyze the potential of the buyers & suppliers and the competitive scenario of the hydroxychloroquine industry for strategy building.
A comprehensive analysis of the factors that drive and restrain the hydroxychloroquine market growth is provided.
The qualitative data about the hydroxychloroquine market trends, dynamics, and developments is provided in the report.
The hydroxychloroquine market size is provided in terms of revenue.
The report provides extensive qualitative insights on the segments and regions exhibiting favorab.

Similar Reports:

Ethylene Vinyl Acetate Resins Market
https://www.alliedmarketresearch.com/ethylene-vinyl-acetate-resins-market

AEA Salicylic Acid Market
https://www.alliedmarketresearch.com/aea-salicylic-acid-market-A15615

Premium Salicylic Acid Market
https://www.alliedmarketresearch.com/premium-salicylic-acid-market

Pharmaceutical Grade Sodium Chloride Market
https://www.alliedmarketresearch.com/pharmaceutical-grade-sodium-chloride-market

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Contact:

David Correa
United States
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int'l: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.